Factors affecting time to maintenance dose in patients initiating warfarin

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 3, 2015-03 ,pp. : 228-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does heart failure exacerbation increase response to warfarin? A critical review of the literature

By Self Timothy H.   Reaves Anne B.   Oliphant Carrie S.   Sands Chris  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2089-2094

Informa Healthcare

Access to resources Recommend Favorite

High carrier prevalence of combinatorial CYP2C9 and VKORC1 genotypes affecting warfarin dosing

By Ruañño Gualberto   Thompson Paul D   Villagra David   Bower Bruce   Kocherla Mohan   Yazdanpanah Golriz   Seip Richard L   Windemuth Andreas   White C Michael   Duconge Jorge   Holford Theodore R   Wu Alan HB  

Personalized Medicine, Vol. 5, Iss. 3, 2008-05 ,pp. : 225-232

Future Medicine

Access to resources Recommend Favorite

Large de novo deletion in chromosome 12 affecting the,,, and genes

By Mallolas Judith   Vilaseca M. Antònia   Pavia Carlos   Lambruschini Nilo   Cambra Francisco José   Campistol Jaume   Gómez David   Carrió Ana   Estivill Xavier   Milà Montserrat  

Journal of Molecular Medicine, Vol. 78, Iss. 12, 2001-02 ,pp. : 721-724

Springer Publishing Company

Access to resources Recommend Favorite

Mutations and Polymorphisms in Genes Affecting Haemostasis Components in Children with Thromboembolic Events

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 5, 2007-01 ,pp. : 392-397

Karger

Access to resources Recommend Favorite